by TractManager | Jul 8, 2024 | Emerging Technology Report
The Corvia Atrial Shunt (formerly the InterAtrial Shunt Device [IASD]; Corvia Medical Inc.) is a transcatheter interatrial shunt under investigation for treatment of heart failure with preserved or midrange ejection fraction.
by TractManager | Jul 5, 2024 | Emerging Technology Report
The FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) is a negative pressure eye goggle indicated for reducing intraocular pressure (IOP) during sleep in adult patients with open-angle glaucoma and IOP ≤ 21 millimeters of mercury who are currently using...
by TractManager | Jul 3, 2024 | Emerging Technology Report
Donanemab (Kisunla; Eli Lilly and Co.) is an intravenously administered amyloid beta-directed antibody indicated for the treatment of Alzheimer disease. Treatment with donanemab should be initiated in patients with mild cognitive impairment or mild dementia stage of...
by TractManager | Jul 1, 2024 | Emerging Technology Report
Eladocagene exuparvovec (PTC Therapeutics) is an investigational gene replacement therapy administered by intraputaminal infusion for the treatment of aromatic L-amino acid decarboxylase deficiency with a severe phenotype in patients aged 18 months and older.
by TractManager | Jun 28, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Lenire (Neuromod Devices Ltd.) bimodal neuromodulation device for the treatment of tinnitus symptoms.
Recent Comments